January 28, 2023

Volume XIII, Number 28

Advertisement

January 27, 2023

Subscribe to Latest Legal News and Analysis

January 26, 2023

Subscribe to Latest Legal News and Analysis

January 25, 2023

Subscribe to Latest Legal News and Analysis
Advertisement

Podcast: Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs – Diagnosing Health Care

In this episode of the Diagnosing Health Care Podcast:  In the aftermath of the Dobbs v. Jackson Women’s Health Organization decision, important questions have emerged about the current legal and regulatory landscape surrounding patient access to drugs that have historically been used to induce abortions.

How can health care providers and pharmacies navigate these new restrictions?

On this episode, Epstein Becker Green attorneys Delia Deschaine, Spreeha Choudhury, and Jessika Tuazon discuss the impact of the Dobbs decision on pharmacies and pharmacists, including patient access to certain reproductive health or abortion-inducing medications, dispensing of drugs, and scope of professional practice requirements.

 

 

©2023 Epstein Becker & Green, P.C. All rights reserved.National Law Review, Volume XII, Number 335
Advertisement
Advertisement
Advertisement

About this Author

Epstein Becker Green has served as a thought leader in the health care industry for more than 40 years. Our attorneys guide clients through complex litigation, corporate transactions, government investigations, FDA and regulatory compliance, privacy and security law, and more.

Health care is in our genes. The breadth of experience delivered by our Health Care and Life Sciences practice—to all players throughout every sector of the health care delivery system—sets us apart. We know the industry inside and out. You might say, it’s in our genes.

312.499.1421
Advertisement
Advertisement
Advertisement